Japan's Takeda Creates U.S. R&D Subsidiary for Antibody Drugs

Takeda Pharmaceutical Co. said Monday that it has established a research and development (R&D) subsidiary in the U.S. that will concentrate on therapeutic antibodies.
TradingMarkets